等待開盤 11-18 09:30:00 美东时间
-0.275
-8.15%
Biotech ETFs are heading into a potentially pivotal week after missing last week’s broader market rally, with two closely watched FDA decisions, Alzheimer’s research updates and obesity-drug developments offering fresh catalysts for the sector. The SPDR S&P Biotech ETF (NYSE:XBI) fell 1.09% last wee...
11-16 22:23
今日重点评级关注:摩根大通:维持CytomX Therapeutics"超配"评级,目标价从11美元升至12美元;康托·菲茨杰拉德:维持Exodus Movement"超配"评级,目标价从15美元升至16美元
11-13 11:50
今日重点评级关注:韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从42美元升至44美元;HC Wainwright & Co.:维持WhiteFiber"买入"评级,目标价从34美元升至36美元
11-12 19:19
Wedbush analyst Robert Driscoll maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and lowers the price target from $30 to $27.
11-11 22:10
Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(1.81) per share which missed the analyst consensus estimate of $(1.20) by 50.83 percent. This is a 4.74 percent increase over losses of $(1.90) per share from the same period last year.
11-10 21:03
Corbus Pharmaceuticals reported key milestones in Q3 2026, including initiating dosing in the TEMPO-1 registrational study for sutantatug envedotin in oropharyngeal cancer and announcing positive topline data for CRB-913 in obesity, showing a 5% weight loss at 12 weeks with favorable safety. The company also appointed a new Chief Medical Officer and reported a net loss of $37.8 million, with $115.3 million in cash on hand.
11-10 13:00
11月10日,Corbus Pharmaceuticals Holdings Inc.(CRBP)收涨14.66%,报3.52美元,成交额444.4万美元,市值...
11-10 08:16
Corbus Pharmaceuticals Holdings, Inc. announced that its CEO, Yuval Cohen, Ph.D., will present at three conferences in November 2026: the Guggenheim 3rd Annual Healthcare Innovation Conference on November 9, 2026; the Jefferies Global Healthcare Conference on November 18, 2026; and the 9th Annual Evercore Healthcare Conference on December 1, 2026. Each event will include presentations, fireside chats, and one-on-one investor meetings. Investors i...
11-05 13:00
11月3日,Corbus Pharmaceuticals Holdings Inc.(CRBP)收跌7.23%,报3.92美元,成交额267.88万美元,市值...
11-03 08:09
10月24日,Corbus Pharmaceuticals Holdings Inc.(CRBP)收跌1.94%,报4.05美元,成交额149.78万美元,市值...
10-24 07:12